07/10/2025
We’re excited to share the launch of our newly updated website, reflecting the evolution of Atelerix Life Sciences and our mission.
Atelerix is focused on precision therapies for respiratory diseases, dedicated to developing novel treatments that address urgent, unmet needs. Our updated site highlights our current pipeline and the innovative work driving our commitment to patients and partners.
Explore the new site here: https://atelerixlifesciences.com/
We look forward to sharing more updates as we advance our programs. If you’re interested in learning more or collaborating, we’d love to connect.
Atelerix Life Sciences is developing ATLX-0199, an active thiol-based compound from our platform of novel drugs, reverses opioid-induced side effects such as OIRD.
